title: Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.
authors.affiliation: Institute of Medical Oncology, Inselspital Bern, Bern, Switzerland. reinhard.zenhaeusern@rsv-gnw.ch
authors.forename: Reinhard
authors.initials: R
authors.lastname: Zenhäusern
authors.forename: Albert
authors.initials: A
authors.lastname: Von Rohr
authors.forename: Kaspar
authors.initials: K
authors.lastname: Rufibach
authors.forename: Max
authors.initials: M
authors.lastname: Solenthaler
authors.forename: Sandrine
authors.initials: S
authors.lastname: Meyer-Monard
authors.forename: Alois
authors.initials: A
authors.lastname: Gratwohl
authors.forename: Urs
authors.initials: U
authors.lastname: Hess
authors.forename: Mario J
authors.initials: MJ
authors.lastname: Bargetzi
authors.forename: Tibor
authors.initials: T
authors.lastname: Kovacsovic
authors.forename: Leda
authors.initials: L
authors.lastname: Leoncini
authors.forename: Andreas
authors.initials: A
authors.lastname: Tobler
mesh_terms: D017338:Cladribine / Q000008:administration & dosage* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D015996:Survival Rate
chemical_list: D017338:Cladribine